COX-2 inhibitors combined with IL-2 strengthened sensitivity of immunotherapy to mice renal cell carcinoma

HU Xiao-yi,CAI Jia-rong,CHU Yi-wei,WANG Guo-min
DOI: https://doi.org/10.3969/j.issn.1672-8467.2013.04.012
2013-01-01
Abstract:Objective: To study the effect of immunotherapy by using cyclooxygenase-2 (COX-2) inhibitors combined with interleukin-2 (IL-2) and its mechanism in mice Renca cell kidney cancer. Methods: After a mouse model of ectopic kidney cancer was established, all 28 mice were divided into 4 groups randomly and treated with different methods (IL-2, NS-398, IL-2+NS-398 and PBS, respectively). Then peripheral blood in tumor-bearing mice was extracted on the 14th day and the 28th day, which were analyzed by flow cytometry to know the changes of regulatory T cells (Treg). The tumors and spleens were all taken off in the end, and immunohistochemistry was used to detect Treg expression. Results: COX-2 inhibitors combined with IL-2 treatment can suppress the tumor growth of Renca cell kidney cancer significantly (P<0.05). COX-2 inhibitors can also down-regulate the expression of Treg in tumor-bearing mice peripheral blood, intra-tumor and spleen. This combination shows synergistic effects. Conclusions: COX-2 inhibitors combined with IL-2 can significantly suppress the development of ectopic kidney cancer in mice, which indicate that Treg reduction may be one of the mechanisms of kidney cancer growth inhibition.
What problem does this paper attempt to address?